VeriMoms-silkworm oligopeptide-1 sp hamilelikte güvenli mi?
No harmonised CLP reproductive classification nor SCCS/CIR safety flags found for oligopeptide-1 or silk-derived peptides. Peer-reviewed literature on topical EGF/oligopeptides indicates local skin activity with minimal systemic exposure, and no evidence of reproductive toxicity in the cosmetic safety literature (CIR/SCCS absent). Therefore default hazard/mechanism scores are 0 and estimated exposure from topical use is negligible (e=0). Sources: CIR (no assessment indicating repro hazard), SCCS absence, PubMed literature on topical EGF safety, CosIng/PubChem listings.
Related ingredients
Frequently asked questions
- s-silkworm oligopeptide-1 sp hamilelikte güvenli mi?
- No harmonised CLP reproductive classification nor SCCS/CIR safety flags found for oligopeptide-1 or silk-derived peptides. Peer-reviewed literature on topical EGF/oligopeptides indicates local skin activity with minimal systemic exposure, and no evidence of reproductive toxicity in the cosmetic safety literature (CIR/SCCS absent). Therefore default hazard/mechanism scores are 0 and estimated exposure from topical use is negligible (e=0). Sources: CIR (no assessment indicating repro hazard), SCCS absence, PubMed literature on topical EGF safety, CosIng/PubChem listings.
- s-silkworm oligopeptide-1 sp emzirirken güvenli mi?
- No evidence of breastmilk transfer or systemic reproductive/breastfeeding-specific toxicity for silk-derived oligopeptides; peptides applied topically generally show low systemic bioavailability, so risk to nursing infants is not indicated. Sources: PubMed on topical peptide absorption, CosIng/PubChem entries; no regulatory flags (ECHA Annex VI/CIR).
- s-silkworm oligopeptide-1 sp bebek cildi için güvenli mi?
- Hazard and mechanism remain 0 (no data indicating reproductive/developmental toxicity). Exposure increased by one level for infants because immature skin barrier and higher surface-area-to-weight can increase systemic uptake; while adult dermal absorption is expected negligible, baby exposure is considered low but measurable (e=1). No infant-specific toxicity data found. Sources: general dermal absorption principles in peer-reviewed literature; regulatory databases (CosIng, PubChem); absence of adverse classifications (ECHA Annex VI/CIR).
- VeriMom s-silkworm oligopeptide-1 sp nasıl puanlıyor?
- VeriMom s-silkworm oligopeptide-1 sp'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte s-silkworm oligopeptide-1 sp yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.